JESSICA KRAMER: Open Payments
NPI 1790239770 · STUDIO CITY, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,704 in 118 payments from 19 companies in 2025. Trend: 2023 $2,269 · 2024 $2,818 · 2025 $4,704
Food & beverage: $3,135Speaker / faculty: $1,500Education: $69
| Company | Payments | Amount |
|---|---|---|
| Journey Medical Corporation | 5 | $1,780 |
| Galderma Laboratories, L.P. | 21 | $457 |
| ABBVIE INC. | 18 | $308 |
| Regeneron Healthcare Solutions, Inc. | 8 | $268 |
| LEO Pharma Inc. | 16 | $242 |
| Arcutis Biotherapeutics, Inc. | 7 | $241 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 6 | $218 |
| Organon LLC | 3 | $189 |
| GENZYME CORPORATION | 4 | $163 |
| E.R. Squibb & Sons, L.L.C. | 2 | $149 |
Products named: DUPIXENT, NEMLUVIO, Zoryve, VTAMA, ILUMYA, ADBRY, Sotyktu, OPZELURA.
Industry payments across CA — which companies pay providers there.
